Erectile Dysfunction Devices Market Report 2026

Erectile Dysfunction Devices Market Overview

• Erectile Dysfunction Devices market size has reached to $2.09 billion in 2025 • Expected to grow to $3.73 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Impact Of Rising Prostate Cancer Rates On The Growth Of The Erectile Dysfunction Device Market • Market Trend: Innovative Non-Invasive Solutions In The Erectile Dysfunction Device Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Erectile Dysfunction Devices Market?

Erectile dysfunction devices are medical tools designed to help individuals with erectile dysfunction (ED) attain and maintain an erection sufficient for sexual activity. These devices operate using different methods, such as suction, constriction, or medication delivery, to improve blood flow to the penis or support its rigidity. The main erectile dysfunction devices are non-surgical devices and surgical devices. Non-surgical devices for erectile dysfunction are tools and products designed to help men achieve and maintain an erection without the need for surgery. It is used for diabetes, neurological disorders, hypertension, and others, and it can be both invasive and non-invasive. It is used for various age groups, including less than 40 years, 40-60 years, and more than 60 years, by several end-users such as hospitals, clinics, ambulatory surgical centers, and others.

What Is The Erectile Dysfunction Devices Market Growth Forecast?

The erectile dysfunction devices market size is expected to see rapid growth in the next few years. It will grow to $3.73 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related disorders, growing male health awareness, increasing acceptance of medical devices for sexual health, expanding access to minimally invasive treatments, improving healthcare infrastructure in emerging markets. Major trends in the forecast period include rising adoption of non-invasive erectile dysfunction devices, growing preference for at-home erectile dysfunction management, increasing demand for vacuum erection and penile pump devices, rising acceptance of surgical penile implants in severe ed cases, growing focus on personalized erectile dysfunction treatment.

Global Erectile Dysfunction Devices Market Segmentation

1) By Device Type: Non-Surgical Devices, Surgical Devices 2) By Cause: Diabetes, Neurological Disorders, Hypertension, Other Causes 3) By Approach: Invasive, Non-Invasive 4) By Age Group: Less Than 40 Years, 40-60 Years, More Than 60 Years 5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Non-Surgical Devices: Penile Pumps (Vacuum Erection Devices), External Penile Prostheses, Erectile Dysfunction Medications (Oral, Topical), Penile Traction Devices, Intraurethral Suppositories 2) By Surgical Devices: Penile Implants (Inflatable, Semi-Rigid), Penile Prostheses (Inflatable, Non-Inflatable), Vascular Surgery Devices (Penile Artery Surgery)

What Is The Driver Of The Erectile Dysfunction Devices Market?

The rise in the prevalence of prostate cancer is expected to propel the growth of the erectile dysfunction devices market going forward. Prostate cancer is a type of cancer that originates in the prostate gland, a small organ located below the bladder in men, which is responsible for producing a component of semen. The rise in prostate cancer cases is attributed to factors such as aging populations, improved detection methods, and lifestyle changes that may contribute to the disease's prevalence. Erectile dysfunction devices assist prostate cancer patients by improving sexual function and quality of life after treatment, which can often impact erectile capabilities. For instance, in September 2025, according to the American Cancer Society, a US-based professional organization, in the United States, an estimated 313,780 new cases of prostate cancer are expected in 2025. The risk of developing prostate cancer increases sharply with age, rising from 0.2% in men under 50 to 6.5% in those aged 70–79. Therefore, the rise in the prevalence of prostate cancer is driving the growth of the erectile dysfunction devices industry.

Key Players In The Global Erectile Dysfunction Devices Market

Major companies operating in the erectile dysfunction devices market are Boston Scientific Corporation, Coloplast Corporation, MTS Medical AG, Alma Lasers Ltd., Shenzhen Huikang Medical Apparatus Co Ltd, Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Rigicon Inc., NOVAmedtek, Vacurect, The Elator, Silimed Indústria de Implantes, Restore Medical Inc, Medtronic plc, Titan Medical Inc, Encore Medical Ltd

Global Erectile Dysfunction Devices Market Trends and Insights

Major companies operating in the erectile dysfunction devices market are developing technologically advanced products, such as non-invasive erectile dysfunction devices, to gain a competitive edge in the market. A non-invasive erectile dysfunction device is a medical tool designed to enhance or restore erectile function without requiring surgical procedures, often utilizing methods like vacuum therapy, electrical stimulation, or penile implants that do not penetrate the body. For instance, in June 2024, Ohh-Med Medical, an Israel-based medical equipment manufacturer, launched the VerticaPlus device for erectile dysfunction. This innovative device features a unique cloud-based mobile app that enhances the therapy experience by offering real-time feedback and quality tracking. The upgraded version incorporates the app as a personal coach throughout the treatment, providing ongoing feedback, step-by-step tutorials, and customized settings to deliver more precise and effective therapy.

What Are Latest Mergers And Acquisitions In The Erectile Dysfunction Devices Market?

In May 2025, Shanghai Taiyuan Life Science, a China-based biotechnology company, formed a partnership with Initia Ltd. to promote next-generation biologic solutions in life sciences. The collaboration aims to improve access to and broaden the distribution of high-quality biologic products, enhancing patient outcomes while fostering innovation and growth in the biologics market. Initia Ltd. is a UK-based biotechnology company focused on the commercialization of advanced biologics for therapeutic applications.

Regional Outlook

North America was the largest region in the erectile dysfunction devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Erectile Dysfunction Devices Market?

The erectile dysfunction devices market consists of sales of penile prostheses, injection therapy devices, urethral suppositories, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.